Targeting tumour-associated macrophages in hodgkin lymphoma using engineered extracellular matrix-mimicking cryogels.
暂无分享,去创建一个
M. Shoichet | R. Goswami | R. Al-awar | J. Kuruvilla | J. Ylanko | D. Uehling | Brigitte L. Thériault | R. Laister | Kela Liu | Laura C. Bahlmann | D. Andrews | M. Yaffe | Yulia Yerofeyeva | C. Xue | Jianan Chen | Arianna Skirzynska | Anne L. Martel | Rachel Peters | Allysia A. Chin | Rashmi S. Goswami | J. Lu | R. Al-Awar | Joy Lu
[1] J. Qiao,et al. The STAT6 inhibitor AS1517499 reduces the risk of asthma in mice with 2,4-dinitrochlorobenzene-induced atopic dermatitis by blocking the STAT6 signaling pathway , 2022, Allergy, Asthma & Clinical Immunology.
[2] A. McGuigan,et al. 3D microgels to quantify tumor cell properties and therapy response dynamics. , 2022, Biomaterials.
[3] J. Zak,et al. Ruxolitinib Plus Nivolumab in Patients with R/R Hodgkin Lymphoma after Failure of Check-Point Inhibitors: Preliminary Report on Safety and Efficacy , 2021, Blood.
[4] A. Zannettino,et al. Fragmentation of tissue-resident macrophages during isolation confounds analysis of single-cell preparations from mouse hematopoietic tissues. , 2021, Cell Reports.
[5] Michael R Hamblin,et al. Immune checkpoint inhibition in classical hodgkin lymphoma , 2021, Expert review of anticancer therapy.
[6] A. McGuigan,et al. Gelatin‐Hyaluronan Click‐Crosslinked Cryogels Elucidate Human Macrophage Invasion Behavior , 2021, Advanced Functional Materials.
[7] L. Xue,et al. Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer , 2021, Journal for ImmunoTherapy of Cancer.
[8] Emre Delen,et al. The Dose Dependent Effects of Ruxolitinib on the Invasion and Tumorigenesis in Gliomas Cells via Inhibition of Interferon Gamma-Depended JAK/STAT Signaling Pathway , 2020, Journal of Korean Neurosurgical Society.
[9] Krasimira T. Petrova,et al. Challenges in Matrix Metalloproteinases Inhibition , 2020, Biomolecules.
[10] M. Shoichet,et al. Designer Biomaterials to Model Cancer Cell Invasion In Vitro: Predictive Tools or Just Pretty Pictures? , 2020, Advanced Functional Materials.
[11] Allen W. Zhang,et al. Single cell transcriptome analysis reveals disease-defining T cell subsets in the tumor microenvironment of classic Hodgkin lymphoma. , 2019, Cancer discovery.
[12] Julia C. Engelmann,et al. High CD206 levels in Hodgkin lymphoma‐educated macrophages are linked to matrix‐remodeling and lymphoma dissemination , 2019, Molecular oncology.
[13] G. Fields. The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma , 2019, Cells.
[14] Gary D Bader,et al. Benchmarking to the Gold Standard: Hyaluronan‐Oxime Hydrogels Recapitulate Xenograft Models with In Vitro Breast Cancer Spheroid Culture , 2019, Advanced materials.
[15] K. Sakamoto,et al. Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma , 2019, BMC Cancer.
[16] M. Farrar,et al. JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors , 2019, Proceedings of the National Academy of Sciences.
[17] W. Sommergruber,et al. 3D-3-culture: A tool to unveil macrophage plasticity in the tumour microenvironment. , 2018, Biomaterials.
[18] H. Drexler,et al. Hodgkin lymphoma cell lines: to separate the wheat from the chaff , 2018, Biological chemistry.
[19] Yu Zhou,et al. An Image Analysis Resource for Cancer Research: PIIP-Pathology Image Informatics Platform for Visualization, Analysis, and Management. , 2017, Cancer research.
[20] M. Shoichet,et al. Independently Tuning the Biochemical and Mechanical Properties of 3D Hyaluronan-Based Hydrogels with Oxime and Diels-Alder Chemistry to Culture Breast Cancer Spheroids. , 2017, Biomacromolecules.
[21] R. Gascoyne,et al. Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin Lymphoma. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] Yiping Yang,et al. Tumor-associated macrophages: implications in cancer immunotherapy. , 2017, Immunotherapy.
[23] M. Saleem,et al. Impact by pancreatic stellate cells on epithelial-mesenchymal transition and pancreatic cancer cell invasion: Adding a third dimension in vitro. , 2016, Experimental cell research.
[24] N. Papo,et al. Matrix metalloproteinase protein inhibitors: highlighting a new beginning for metalloproteinases in medicine , 2016 .
[25] J. Al-Maghrabi,et al. High tumour-associated macrophages infiltration is correlated with poor survival outcome in classical Hodgkin’s lymphoma , 2015 .
[26] H. McKenzie,et al. How I treat advanced classical Hodgkin lymphoma. , 2015, Blood.
[27] D. Scott,et al. The classical Hodgkin lymphoma tumor microenvironment: macrophages and gene expression-based modeling. , 2014, Hematology. American Society of Hematology. Education Program.
[28] C. Simmler,et al. Importance of Purity Evaluation and the Potential of Quantitative 1H NMR as a Purity Assay , 2014, Journal of medicinal chemistry.
[29] R. Gascoyne,et al. The tumour microenvironment in B cell lymphomas , 2014, Nature Reviews Cancer.
[30] Poonam Kothari,et al. IL-6–Mediated Induction of Matrix Metalloproteinase-9 Is Modulated by JAK-Dependent IL-10 Expression in Macrophages , 2014, The Journal of Immunology.
[31] C. Lan,et al. Expression of M2-Polarized Macrophages is Associated with Poor Prognosis for Advanced Epithelial Ovarian Cancer , 2013, Technology in cancer research & treatment.
[32] Stéphanie Balor,et al. The Process of Macrophage Migration Promotes Matrix Metalloproteinase-Independent Invasion by Tumor Cells , 2011, The Journal of Immunology.
[33] E. Morii,et al. Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma , 2011, Virchows Archiv.
[34] Steven J. M. Jones,et al. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. , 2010, The New England journal of medicine.
[35] F. Gauffre,et al. Matrix Architecture Dictates Three-Dimensional Migration Modes of Human Macrophages: Differential Involvement of Proteases and Podosome-Like Structures , 2009, The Journal of Immunology.
[36] Y. Chiba,et al. A novel STAT6 inhibitor AS1517499 ameliorates antigen-induced bronchial hypercontractility in mice. , 2009, American journal of respiratory cell and molecular biology.
[37] D. Chung,et al. Endotoxin Contamination in Commercially Available Pokeweed Mitogen Contributes to the Activation of Murine Macrophages and Human Dendritic Cell Maturation , 2006, Clinical and Vaccine Immunology.
[38] Michael V Sefton,et al. Endotoxin: the uninvited guest. , 2005, Biomaterials.
[39] Jyrki Heino,et al. Integrin-mediated Cell Adhesion to Type I Collagen Fibrils* , 2004, Journal of Biological Chemistry.
[40] A. Kanık,et al. Prognostic value of matrix metalloproteinases (MMP‐2 and MMP‐9) in Hodgkin's and non‐Hodgkin's lymphoma , 2004, International journal of clinical practice.
[41] S. Pileri,et al. Hodgkin's lymphoma: the pathologist's viewpoint. , 2002, Journal of clinical pathology.
[42] A. Ruifrok,et al. Quantification of histochemical staining by color deconvolution. , 2001, Analytical and quantitative cytology and histology.
[43] A. Delmas,et al. Identification of by-products from an orthogonal peptide ligation by oxime bonds using mass spectrometry and tandem mass spectrometry. , 2000, Rapid communications in mass spectrometry : RCM.
[44] Michael C. Ostrowski,et al. Macrophage Colony-stimulating Factor Promotes Cell Survival through Akt/Protein Kinase B* , 1999, The Journal of Biological Chemistry.
[45] C. von Kalle,et al. Preliminary report: growth of Hodgkin's lymphoma derived cells in immune compromised mice. , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.
[46] K. Alitalo,et al. Fibronectin is produced by human macrophages , 1980, The Journal of experimental medicine.